| Nucleus Basalis of Meynert Cholinergic Neurons | |
|---|---|
| Basal Forebrain Cholinergic System | |
| Allen Atlas ID | Mouse: GSN0002005 |
| Lineage | Neuron > GABAergic > Basal Forebrain Cholinergic |
| Markers | ChAT, p75NTR (NGFR), SLC18A3 (VAChT), NGF, BDNF |
| Brain Regions | Substantia innominata, Horizontal Diagonal Band, Vertical Diagonal Band |
| Disease Vulnerability | [Alzheimer's Disease](/diseases/alzheimers-disease), [Dementia with Lewy Bodies](/diseases/dementia-lewy-bodies), [Parkinson's Disease](/diseases/parkinsons-disease) |
Nucleus Basalis Meynert Cholinergic Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Nucleus Basalis of Meynert (NBM) is the largest cholinergic nuclei in the basal forebrain and serves as the primary source of cortical acetylcholine. These projection neurons are essential for cortical activation, attention, learning, and memory consolidation [1][2]. The NBM is severely affected in Alzheimer's disease (AD), where degeneration of these cholinergic neurons underlies the characteristic cognitive decline and represents a key therapeutic target for symptomatic treatment [3][4].
The NBM is part of the basal forebrain cholinergic system (BFCS), which includes the medial septum (MS), vertical and horizontal diagonal bands of Broca (VDB/HDB), and the nucleus basalis of Meynert proper. Together, these nuclei provide the majority of cholinergic innervation to the hippocampus and neocortex [5].
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:0000108 | cholinergic neuron |
| Database | ID | Name | Confidence |
|---|---|---|---|
| Cell Ontology | CL:0000108 | cholinergic neuron | Medium |
| Cell Ontology | CL:2000056 | Meynert cell | Medium |
The NBM is located in the substantia innominata of the basal forebrain:
NBM cholinergic neurons receive inputs from:
Cortical projection patterns:
| Target Region | Function | Cholinergic Modulation |
|---|---|---|
| Prefrontal Cortex | Executive function, working memory | Enhances signal-to-noise ratio [13] |
| Parietal Cortex | Spatial attention, sensory integration | Facilitates perceptual learning [14] |
| Temporal Cortex | Object recognition, memory | Enables long-term potentiation [15] |
| Hippocampus | Episodic memory, navigation | Critical for theta oscillations [16] |
NBM cholinergic neurons exhibit distinctive electrophysiological characteristics:
Acetylcholine release mechanisms:
| Gene | Protein | Function |
|---|---|---|
| CHAT | Choline Acetyltransferase | ACh synthesis enzyme |
| NGFR | p75NTR | NGF receptor (low-affinity) |
| SLC18A3 | VAChT | Vesicular ACh transport |
| BDNF | Brain-Derived Neurotrophic Factor | Neurotrophic support |
| NTRK1 | TrkA | High-affinity NGF receptor |
Single-nucleus RNA sequencing has identified NBM-specific transcriptional programs [25]:
NBM degeneration is a hallmark of AD neuropathology:
NBM involvement in DLB:
Cholinergic changes in PD:
| Drug | Mechanism | Efficacy |
|---|---|---|
| Donepezil | AChE inhibition | Moderate cognitive improvement [42] |
| Rivastigmine | AChE/BuChE inhibition | Benefits cognition and function [43] |
| Galantamine | AChE modulation + nAChR agonism | Enhances cholinergic signaling [44] |
| Memantine | NMDA antagonism | Complements cholinergic therapy [45] |
The study of Nucleus Basalis Meynert Cholinergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Cholinergic basal forebrain anatomy and function. Trends Neurosci. 2020. ↩︎ ↩︎
Basal forebrain cholinergic circuits in cognition. Neuron. 2020. ↩︎ ↩︎
NBM degeneration in Alzheimer's disease. Acta Neuropathol. 2019. ↩︎ ↩︎
Cholinergic therapy in neurodegenerative disease. Neuropharmacology. 2018. ↩︎ ↩︎
Basal forebrain cholinergic system organization. J Comp Neurol. 2017. ↩︎
Neuroanatomy of the basal forebrain. Neuroscience. 2016. ↩︎
Ch1-Ch4 cholinergic cell groups. J Chem Neuroanat. 2015. ↩︎
Basal forebrain neurovascular relationships. J Cereb Blood Flow Metab. 2014. ↩︎
Brainstem inputs to basal forebrain. Neuroscience. 2013. ↩︎
Hypothalamic modulation of NBM. Brain Struct Funct. 2012. ↩︎
Substantia nigra projections to basal forebrain. J Neurosci. 2011. ↩︎
Corticopetal projections to basal forebrain. Cereb Cortex. 2010. ↩︎
Basal forebrain circuits in attention and memory. Nat Neurosci. 2018. ↩︎ ↩︎
Cholinergic modulation of sensory cortex. J Neurosci. 2017. ↩︎
ACh and hippocampal plasticity. Hippocampus. 2016. ↩︎
Cholinergic theta rhythm generation. Nat Neurosci. 2015. ↩︎
Burst firing in NBM neurons. J Neurosci. 2014. ↩︎
Tonic firing properties. J Neurophysiol. 2013. ↩︎
State-dependent activity. Sleep. 2012. ↩︎
Theta phase locking. Neuron. 2011. ↩︎
Vesicular acetylcholine transport. Pharmacol Rev. 2010. ↩︎
Dendritic spike propagation. J Neurosci. 2009. ↩︎
Volume transmission in basal forebrain. Neuroscientist. 2008. ↩︎
Cholinergic receptor subtypes. Brain Res Rev. 2007. ↩︎
Single-nucleus transcriptomics of basal forebrain. Nat Neurosci. 2020. ↩︎
NBM neuron loss quantification. Acta Neuropathol. 2019. ↩︎
Tau pathology in NBM. Brain. 2018. ↩︎
Amyloid deposition in basal forebrain. Neurobiol Aging. 2017. ↩︎
Cortical cholinergic denervation. Brain. 2016. ↩︎
AChE inhibitor efficacy. Lancet Neurol. 2015. ↩︎
Lewy bodies in NBM. Neurology. 2014. ↩︎
Cholinergic deficits in DLB. Brain. 2013. ↩︎
Fluctuations and cholinergic dysfunction. Ann Neurol. 2012. ↩︎
DLB treatment response. Neurology. 2011. ↩︎
PPN degeneration in PD. Brain. 2010. ↩︎
PD-MCI cholinergic basis. Neurology. 2019. ↩︎
Cholinergic gait control. Ann Neurol. 2018. ↩︎
RBD and cholinopathy. Neurology. 2017. ↩︎
NBM in Down syndrome. Acta Neuropathol. 2016. ↩︎
Vascular cognitive impairment. Stroke. 2015. ↩︎
MCI progression prediction. Neurology. 2014. ↩︎
Donepezil efficacy. Cochrane Database Syst Rev. 2013. ↩︎
Rivastigmine in practice. J Alzheimers Dis. 2012. ↩︎
Galantamine mechanisms. CNS Drugs. 2011. ↩︎
Memantine add-on therapy. Alzheimers Dement. 2010. ↩︎
p75NTR agonists for neurodegeneration. Neurobiol Dis. 2019. ↩︎
Cell therapy approaches. Stem Cell Reports. 2018. ↩︎
Gene therapy for cholinergic enhancement. Mol Ther. 2017. ↩︎
NBM deep brain stimulation. Neurology. 2016. ↩︎
AAV-NGF trial (CERE-110). Mol Ther. 2014. ↩︎
DBH-NGF fusion proteins. Gene Ther. 2013. ↩︎
Mecamylamine cognitive effects. Psychopharmacology. 2012. ↩︎